​Dave Pearce, Senior Associate

Dave has led operations and development for a number of medical device and pharmaceutical companies. He has extensive experience with a wide range of drug delivery, drug/device combination products and medical devices. His areas of expertise include the following:

  • Product Design, Development, Manufacturing, Quality, Supply Chain and Facilities Management
  • Interim management, Alliance Management, and Due Diligence 

Affiliates and Associates

She has managed the development of over ninety drugs derived from a diverse range of molecular and cellular entities. Her expertise, experience and understanding of the challenges and complexities of integration of components of combination products has resulted in the commercial success of a wide range of products. 

Prior to ECG, Sheryl worked at Sterling Drug, Centocor, Bayer, Genentech and most recently was Global Head of Biologics Pharmaceutical Development at Novartis in Basel.

Sheryl received her Ph.D. in Cell Biology from the University of Vermont and was a postdoctoral fellow in Biochemistry at the University of California, Berkeley.

Carol has developed and implemented product and technology development and manufacturing strategies for over sixty products and led launch teams for over one hundred.

Prior to ECG, Carol was COO at NuGen Technologies, VP Device Manufacturing at Nektar, and Director of Operations at both Syntex (Roche) and BioRad. She also held Operations and Quality management roles at Warner Lambert (Pfizer).

Carol is a graduate of Texas Christian University with a BS/MS in Medical Technology and Biochemistry and the Executive Management Program at Stanford University.

Car​ol Nast, Founder and President

Carol is a seasoned executive with extensive experience in the Healthcare and Life Science industries. Her areas of expertise include:

  • ​Interim Management, Due Diligence, Alliance Management
  • Technology and Product Development and Commercialization
  • Establishment of Quality, Development, Manufacturing and Supply Chain processes and systems
Anthony specializes in assessing and establishing the optimized infrastructure for alliance and program management. He has successfully managed large-scale global development and strategic projects for Biopharmaceuticals, Diagnostics and Combination Products. He has implemented global regulatory strategies to ensure that all activities were conducted in compliance with relevant laws, regulations, and guidance including manufacturing, research, clinical, and quality assurance.

Prior to ECG Anthony worked in management roles at Novartis Vaccines and Diagnostics, Itero Biopharmaceuticals, Novo Nordisk,  and Aradigm. He has a double B. Sc. from the University of California at Santa Barbara in Pharmacology and in Biopsychology.

Prior to ECG, Dave was VP of Product Development and Operations at Biomerix, VP of Operations at Ouroboros Medical, VP of Manufacturing and Service at Hansen Medical, Senior Director of Supply Chain and Manufacturing Operations at Aradigm and Plant Manager/Site Director for Abbott Laboratories.

Dave holds a BS in Industrial Engineering from the University of Texas and a Master of Engineering from Arizona State University.

Rick has been a key participant in product development for over fifteen companies and has specific expertise in material science, primary packaging, electrochemistry, films, and laminates, and manufacturing expertise in form/fill/seal, assembly, extrusion, coating, injection molding, and converting processes. He also has extensive experience with the generation of specific deliverables associated with compliance to regulatory requirements and current industry standards.

Prior to ECG, Rick worked in engineering and management roles at Novo Nordisk, Aradigm and Roche Diagnostics and the 3M company. He has a M.S. in Chemical Engineering from the University of Connecticut at Storrs.

​Leadership Team

Rick Bodensteiner, Senior Associate

​Rick has over thirty years of engineering and management experience in the Healthcare and Life Sciences Industries. His areas of expertise include:

  • ​Development and Commercialization of Combination Products, Medical Devices and Diagnostics
  • Technology and Product Development Planning and Requirements, Risk Management, Product and Process Improvements, Design Control, Technology Transfer and Alliance Management
  • Development and implementation of Quality and Development processes and systems

Pamella Montgomery, PhD, Principal
Pam has 22 years of experience in Pharmaceutical and Life Science industries. Her areas of expertise include the following:

  • ​Quality Systems and Compliance for Pharmaceutical companies

  • Design, Establishment and Management of comprehensive Development and Commercialization programs for Process and Analytical Validation, Risk Assessments, Knowledge Management, Quality by Design and Technology Transfers

  • Experienced Auditor for cGMP and cGCP sites and programs

​Anthony Queirolo, Senior Associate

Anthony has 18 years of experience in Life Science industries. His areas of expertise include the following:

  • Alliance and Program Management of Biopharmaceutical, Medical Diagnostic and Combination Products
  • Program Management, Development Processes, Commercial Launch Planning, Risk Assessments, Clinical Operations Management 

Pam is experienced in CMC development and commercialization ​and specializes in designing, managing and ensuring compliance for product programs. 

Pam has been a successful consultant for 19 years before joining ECG. Prior to that she has worked at Applied Biosystems and Pharmacia. 

She has a PhD in Nutritional Biochemistry with a Molecular Biology minor from the University of California, Berkeley. She was a Postdoctoral Fellow at University of California Berkeley in Nutrition and at the University of California, San Francisco in the Cancer Research Institute.

Sheryl Martin-Moe, PhD, Executive Vice President

Sheryl has led drug and combination product development for large multi-national biologics and pharmaceutical companies.  Her areas of expertise include:

  • ​Development and Commercialization of Pharmaceuticals and Combination Products 
  • Technology and Product Strategies, Requirements, Concept and Process Improvements and Alliance Management
  • Establishment of Development, Quality Systems, Manufacturing, Quality by Design, Comparability, Technical Transfer and Operational Excellence processes and systems